IMUX - upcoming catalysts - insidersThis is not a financial advice!
I see a test of 3, if we break we might seeing a gap fill.
Most info on the chart.
Trade carefully!
IMUX trade ideas
IMUX monitoringIMUX is trading with high trading volume.
there is a divergence in the RSI indicator.
5K - 10K Challenge (Trade 003)OK traders, this is not trading advice.
I am attempting to turn 5K (approx) into 10k over the rest of the year for a bit of fun and hopefully a bit of profit!!
This is trade number 3 today, IMUX is a stock I am quite familiar with, I've lost lots of money with this stock ha ha!
IMUX has a trading range between 8 and 13... what I would call a heavily manipulated stock. It has an impressive pipeline and should have results coming in June that will cause a spike, I'm looking to make 20% on the bounce from the freefall of the last few days.
Good level of support where it is now and hopefully this was just the MM manipulating the stock, have set a buy price of 8.2 so let's see what happens, I expect o be in this trade for a few weeks.
GLTA
Immunic impressive pipeline and ready to go 80% this yearNot much I can say about Immunic that you probably don't already know if you're looking at this, they have dropped nicely lately, this is the bottom it looks like and this ompany has a very impressive pipeline, been waiting a long time to get back into this and I consider this a sale price. At worst you'll make an easy 10 % but with so many catalysts on the way for this stock in the next year it seems like 100% is achievable.
www.immunic-therapeutics.com
I am betting on the Ulcerative Colitis angle for this as the market is massive, they have had very favorable results so far and it's only a matter of time before more positive results are announced.
For entertainment purposes only. Stocks go up, stocks go down.
IMUX heading higherIMUX has been trading in the channel for over 6 months.
Now it seems it is trying to break it.
If it stands the support at 20.20 (used to be resistance), it may look like a good BUY signal.
Alternatively, can try to wait if it drops back to the support at 15.00.
I think I will give it a try now.
IMUX, price may drop as it breaks higher Bollinger Band on Feb 8This price move could be a signal that IMUX may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options. Tickeron's A.I.dvisor backtested 41 similar cases where IMUX's price broke its higher Bollinger Band, and 37 of them led to a successful outcome. Odds of Success: 90%. Current price $20.32 crossed the support line at $19.51 and is trading between $20.37 resistance and $19.51 support lines. Throughout the month of 01/06/21 - 02/08/21, the price experienced a +17% Uptrend. During the week of 02/01/21 - 02/08/21, the stock enjoyed a +16% Uptrend growth.
Bearish Trend Analysis
The Stochastic Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day Moving Average for IMUX crossed bearishly below the 50-day moving average on December 29, 2020. This indicates that the trend has shifted lower and could be considered a sell signal. Tickeron A.I. detected that in 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMUX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for IMUX entered a downward trend on January 07, 2021. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
IMUXIMUX, it seems to me in an accumulation phase, phase trapped in a triangle, the eventual breakdown of the descending train will give us confirmation that the lateral phase is over
IMUX, Stochastic Oscillator left the oversold zone on January 06This is a signal that IMUX's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. Tickeron's A.I.dvisor identified 68 similar cases where IMUX's stochastic oscillator exited the oversold zone, and 59 of them led to successful outcomes. Odds of Success: 87%. Current price $17.27 crossed the support line at $17.15 and is trading between $17.89 support and $17.15 support lines. Throughout the month of 12/03/20 - 01/06/21, the price experienced a -7% Downtrend, while the week of 12/29/20 - 01/06/21 shows a +2% Uptrend.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IMUX's RSI Indicator exited the oversold zone, 32 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Stochastic Indicator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. Tickeron A.I. detected in 59 of 68 cases where IMUX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
Following a +3.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMUX advanced for three days, in 204 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
IMUX to gain 20%+IMUX has without doubt one of the most impressive pipelines I have seen in biotech, the potential here is just massive. I bought stock and I am not selling, this will be good news after good news after more good news.
I listened to hour long call with CEO and some of the highlights are as follows:
IMU-838 - They have an excellent MS treatment in trials producing great results, up to 70% reductions in MRI lesions
IMU-856 - Also a potentially game changing treatment for Crohn's/Ulcerative Colitis, that does not rely on harsh steroids but repairs the permeability of the gut lining.
IMU-935 - Also a treatment for psoriasis
If any one of these drugs came to fruition the sales would be massive, if all three of them come to pass then this stock price will go to multiples over the next two or three years.
Good luck trading, if you know anymore about this company then please comment as it almost seems to good to be true ....
Not a professional please do your own research
Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis
Study Meets Primary and Key Secondary Endpoints with High Statistical Significance
Statistically Significant Reduction of 62% and 70%
Data Supports Previously Observed Favorable Safety Profile of IMU-838 in Relapsing-Remitting Multiple Sclerosis Patient Population -
- Company Also Reports Second Quarter 2020 Financial Results With $48.6 Million in Cash and Cash Equivalents -
finance.yahoo.com
IMUX Longgreat stock, it is up for a gap today but i do believe it will come back down to 17.50-15.49 which i think would be a great opportunity to buy knowing their current progress. they have announce their first patient for Covid 19 and are sponsored for it. I think the stock has potential to reach $21 with the current rate.
IMUX - opportunities in the ascending channel!Long and short position setup based on trend line analysis and candle stick confirmations.
$IMUX Immunic Inc On Breakout Watch Major breakout potential
Golden cross complete
Company Profile
Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.
$IMUX Lotto PlayTargeting $15 next week. Announcement of COVID 19 treatment trials in place. Stop loss at $9.00.
Immunic Inc Rises on trial data shares are trading higher after the company reported its IMU-838 demonstrated preclinical activity against the coronavirus SARS-CoV-2 it is exploring plans for a Phase 2 clinical trial in coronavirus patients. Source seekignalpha
